Boundary layer infusion of nitric oxide reduces early smooth muscle cell proliferation in the endarterectomized canine artery

被引:29
作者
Chen, CY
Hanson, SR
Keefer, LK
Saavedra, JE
Davies, KM
Hutsell, TC
Hughes, JD
Ku, DN
Lumsden, AB
机构
[1] VET AFFAIRS MED CTR, DEPT SURG, DECATUR, GA 30033 USA
[2] EMORY UNIV, SCH MED, ATLANTA, GA 30322 USA
[3] NCI, FREDERICK CANC RES & DEV CTR, FREDERICK, MD 21702 USA
[4] GEORGE MASON UNIV, DEPT CHEM, FAIRFAX, VA 22030 USA
[5] COMEDICUS INC, COLUMBIA HTS, MN 55421 USA
关键词
D O I
10.1006/jsre.1996.4915
中图分类号
R61 [外科手术学];
学科分类号
摘要
To evaluate the direct effect of nitric oxide (NO) on vascular smooth muscle cell (SMC) proliferation in vivo, we used an expanded polytetrafluoroethylene (ePTFE)-based local infusion device to deliver an NO donor, proline/NO (PROLI/NO), to the luminal boundary layer of endarterectomized artery and the distal anastomosis of the graft in a canine model. Once delivered to the blood, PROLI/NO releases NO by a mechanism involving pH-dependent decomposition. Six dogs underwent bilateral femoral artery endarterectomies. ePTFE infusion devices, blindly primed with PROLI/NO to one artery or proline to the contralateral vessel, were anastomosed proximal to the injured segments so that each animal served as its own control. PROLI/NO or proline was continuously delivered for 7 days from an osmotic reservoir, through the wall of the graft infusion device. Euthanasia was carried out at 7 days, and the processed specimens were blindly analyzed for SMC proliferation at both graft anastomoses and endarterectomized segments by a bromodeoxyuridine index assay. All dogs survived with no clinical side effects. In comparing the treated and control vessels, NO released from PROLI/NO significantly reduced SMC proliferation by 43% (13.24 +/- 1.24% versus 23.24 +/- 1.01%, P = 0.004) at the distal anastomoses and by 68% (10.58 +/- 1.63% versus 25.17 +/- 3.39%, P = 0.007) at endarterectomized segments. However, there was no significant difference in blood flow measurements between treated and control arteries (56.25 +/- 6.50 ml/min versus 46.50 +/- 3.20 ml/min, P = 0.094). These data demonstrate that local boundary layer infusion of NO released from PROLI/NO significantly reduces SMC proliferation in injured arteries with no effect on regional blood flow. This study suggests a new strategy to inhibit early SMC proliferation in injured arteries and probably to control intimal hyperplastic lesion formation in the manipulated vessels. (C) 1997 Academic Press.
引用
收藏
页码:26 / 32
页数:7
相关论文
共 41 条
[1]  
CHEN C, 1996, IN PRESS CARDIOVASC
[2]   BOUNDARY-LAYER INFUSION OF HEPARIN PREVENTS THROMBOSIS AND REDUCES NEOINTIMAL HYPERPLASIA IN VENOUS POLYTETRAFLUOROETHYLENE GRAFTS WITHOUT SYSTEMIC ANTICOAGULATION [J].
CHEN, CY ;
HANSON, SR ;
LUMSDEN, AB .
JOURNAL OF VASCULAR SURGERY, 1995, 22 (03) :237-247
[3]   Transgraft infusion of heparin to prevent early thrombosis of expanded PTFE grafts in canine femoral veins [J].
Chen, CY ;
Hughes, JD ;
Mattar, SG ;
Hanson, SR ;
Lumsden, AB .
ANNALS OF VASCULAR SURGERY, 1996, 10 (02) :147-155
[4]  
CLAGETT G P, 1986, Journal of Vascular Surgery, V3, P10, DOI 10.1067/mva.1986.avs0030010
[5]  
CLAGETT G P, 1989, Journal of Vascular Surgery, V10, P577
[6]  
CLOWES AW, 1983, LAB INVEST, V49, P327
[7]  
CLOWES AW, 1986, LAB INVEST, V54, P295
[8]  
DIODATI JG, 1993, THROMB HAEMOSTASIS, V70, P654
[9]   COMPLEXES OF NITRIC-OXIDE WITH NUCLEOPHILES AS AGENTS FOR THE CONTROLLED BIOLOGICAL RELEASE OF NITRIC-OXIDE - HEMODYNAMIC-EFFECT IN THE RABBIT [J].
DIODATI, JG ;
QUYYUMI, AA ;
KEEFER, LK .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1993, 22 (02) :287-292
[10]  
DRAPIER JC, 1988, J IMMUNOL, V140, P2829